Drugs / ChimeriVax™-Japanese Encephalitis Vaccine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00981630 | Nov 2004 → Feb 2006 | Japanese encephalitis | Sanofi | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ChimeriVax-Japanese Encephalitis Vaccine | “Study of Live Attenuated ChimeriVax™-Japanese Encephalitis Vaccine” NCT00981630 ↗ |
| Modality | Vaccine | “Live Attenuated ChimeriVax™-Japanese Encephalitis Vaccine” NCT00981630 ↗ |
| Route | Subcutaneous | “0.5 mL,Subcutaneous” NCT00981630 ↗ |